Oral-Systemic Link: Page 48

FDA awards $1.1M for immunotherapy research
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has awarded a $1.1 million grant for research on oropharynx cancer related to human papillomavirus.
September 13, 2015
Study: Oral rinse may predict return of HPV-related OPC
By Donna Domino
An oral rinse may be able to predict the recurrence of oropharyngeal cancer (OPC) related to human papillomavirus (HPV), according to a new study in JAMA Oncology. The research findings may enable earlier detection of recurrence and new monitoring protocols.
September 13, 2015
2013 09 03 14 41 25 490 Hpv 200
CDC: More high school athletes using smokeless tobacco
By DrBicuspid.com staff writers
High school athletes who play on sports teams smoke tobacco at a lower rate than nonathletes, but use smokeless tobacco more, according to a study by the U.S. Centers for Disease Control and Prevention (CDC).
September 2, 2015
Soligenix adds subjects for mucositis treatment study
By DrBicuspid.com staff writers
Biopharmaceutical company Soligenix has completed enrollment of additional subjects in the phase II study for its SGX942 oral mucositis treatment.
August 30, 2015
Week in Review: Enhanced oral cancer detection can save lives and protect from malpractice
By Tony Edwards
August 20, 2015
CDA Presents 2015: Enhanced oral cancer detection can save lives
By Donna Domino
SAN FRANCISCO - Enhanced oral cancer detection can help save patients' lives while protecting dentists from malpractice lawsuits, according to a presentation by Dr. Jonathan Bregman at this week's California Dental Association's CDA Presents 2015 meeting. Effective protocols for screening and high-tech detection devices will help stem the disease's growing incidence, especially among young people.
August 20, 2015
2015 08 20 14 30 18 240 2015 Cda Presents Thumb
UT gets $144K grant to study oral cancer pain
By DrBicuspid.com staff writers
The University of Texas (UT) Health Science Center at San Antonio has received a $144,000 grant from the American Cancer Society to study oral cancer pain.
August 16, 2015
MedImmune acquires rights to Inovio's HPV vaccine
By DrBicuspid.com staff writers
Inovio Pharmaceutial has entered into a license agreement with MedImmune for its INO-3112 immunotherapy for cancers caused by human papillomavirus (HPV) and also a collaboration to develop new cancer vaccines, the companies announced.
August 9, 2015
Curt Schilling supports Boston ban on smokeless tobacco
By DrBicuspid.com staff writers
Former Major League Baseball pitcher and oral cancer survivor Curt Schilling is supporting a Boston proposal to ban smokeless tobacco in public and private sports venues used by both amateurs and professionals.
August 5, 2015
Do HPV16 antibodies predict oral cancer survival?
By Donna Domino
A specific antibody to human papillomavirus type 16 (HPV16) improved the survival of patients with HPV-positive oropharyngeal squamous cell carcinoma in a new study in Clinical Cancer Research. Specific antibody status can be used to alter treatments for such patients.
August 5, 2015
2013 09 03 14 41 25 490 Hpv 200
CDC: Many U.S. adolescents not getting HPV vaccine
By Donna Domino
The number of 13- to 17-year-old boys and girls in the U.S. receiving the human papillomavirus (HPV) vaccine has increased for the second year in a row, but about half of all U.S. adolescents still haven't received it, according to a new report from the Centers for Disease Control and Prevention (CDC).
July 30, 2015
2013 09 03 14 41 25 490 Hpv 200
DrBicuspid.com Oral Cancer & Diagnostics Insider: HPV16 antibodies & survival rates
By Donna Domino
July 29, 2015
Previous Page
Page 48 of 151
Next Page